vs
Esperion Therapeutics, Inc.（ESPR）与LANDS' END, INC.（LE）财务数据对比。点击上方公司名可切换其他公司
LANDS' END, INC.的季度营收约是Esperion Therapeutics, Inc.的1.9倍（$317.5M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 0.1%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -0.9%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Lands' End是1963年诞生于美国芝加哥的服饰零售品牌，最初以邮购游艇用品起家，目前业务拓展至服饰、箱包与家居用品领域。截至2024年2月，品牌在美国本土共开设26家门店，总部位于威斯康星州道奇维尔。品牌名源自地名兰兹角，因创立时印刷错了撇号位置又无力重印，错拼的名称便沿用至今。
ESPR vs LE — 直观对比
营收规模更大
LE
是对方的1.9倍
$168.4M
营收增速更快
ESPR
高出143.6%
0.1%
两年增速更快
ESPR
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $317.5M |
| 净利润 | — | $5.2M |
| 毛利率 | — | 51.8% |
| 营业利润率 | 50.6% | 5.3% |
| 净利率 | — | 1.6% |
| 营收同比 | 143.7% | 0.1% |
| 净利润同比 | — | 198.3% |
| 每股收益（稀释后） | $0.32 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRLE
| Q4 25 | $168.4M | $317.5M | ||
| Q3 25 | $87.3M | — | ||
| Q2 25 | $82.4M | $261.2M | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $69.1M | $318.6M | ||
| Q3 24 | $51.6M | $317.2M | ||
| Q2 24 | $73.8M | $285.5M | ||
| Q1 24 | $137.7M | $514.9M |
净利润ESPRLE
| Q4 25 | — | $5.2M | ||
| Q3 25 | $-31.3M | — | ||
| Q2 25 | $-12.7M | $-8.3M | ||
| Q1 25 | $-40.5M | — | ||
| Q4 24 | — | $-593.0K | ||
| Q3 24 | $-29.5M | $-5.3M | ||
| Q2 24 | $-61.9M | $-6.4M | ||
| Q1 24 | $61.0M | $-8.6M |
毛利率ESPRLE
| Q4 25 | — | 51.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 50.8% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 50.6% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 48.7% | ||
| Q1 24 | — | 38.0% |
营业利润率ESPRLE
| Q4 25 | 50.6% | 5.3% | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | 8.6% | -0.9% | ||
| Q1 25 | -34.0% | — | ||
| Q4 24 | -6.4% | 2.9% | ||
| Q3 24 | -31.0% | 0.8% | ||
| Q2 24 | 3.5% | 0.8% | ||
| Q1 24 | 52.5% | 1.6% |
净利率ESPRLE
| Q4 25 | — | 1.6% | ||
| Q3 25 | -35.9% | — | ||
| Q2 25 | -15.4% | -3.2% | ||
| Q1 25 | -62.2% | — | ||
| Q4 24 | — | -0.2% | ||
| Q3 24 | -57.2% | -1.7% | ||
| Q2 24 | -83.9% | -2.3% | ||
| Q1 24 | 44.3% | -1.7% |
每股收益（稀释后）ESPRLE
| Q4 25 | $0.32 | $0.17 | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | $-0.27 | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | $-0.02 | ||
| Q3 24 | $-0.15 | $-0.17 | ||
| Q2 24 | $-0.33 | $-0.20 | ||
| Q1 24 | $0.34 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $36.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $231.0M |
| 总资产 | $465.9M | $852.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRLE
| Q4 25 | $167.9M | $36.3M | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | $18.1M | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | $30.4M | ||
| Q3 24 | $144.7M | $25.6M | ||
| Q2 24 | $189.3M | $27.4M | ||
| Q1 24 | $226.6M | $25.3M |
股东权益ESPRLE
| Q4 25 | $-302.0M | $231.0M | ||
| Q3 25 | $-451.4M | — | ||
| Q2 25 | $-433.5M | $230.1M | ||
| Q1 25 | $-426.2M | — | ||
| Q4 24 | $-388.7M | $223.6M | ||
| Q3 24 | $-370.2M | $226.5M | ||
| Q2 24 | $-344.2M | $234.6M | ||
| Q1 24 | $-294.3M | $241.6M |
总资产ESPRLE
| Q4 25 | $465.9M | $852.7M | ||
| Q3 25 | $364.0M | — | ||
| Q2 25 | $347.1M | $760.5M | ||
| Q1 25 | $324.0M | — | ||
| Q4 24 | $343.8M | $843.6M | ||
| Q3 24 | $314.1M | $802.5M | ||
| Q2 24 | $352.3M | $800.1M | ||
| Q1 24 | $373.1M | $811.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-15.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-22.4M |
| 自由现金流率自由现金流/营收 | — | -7.1% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | — | -3.03× |
| 过去12个月自由现金流最近4个季度 | — | $-55.0M |
8季度趋势，按日历期对齐
经营现金流ESPRLE
| Q4 25 | $45.2M | $-15.7M | ||
| Q3 25 | $-4.3M | — | ||
| Q2 25 | $-31.4M | $-22.5M | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $-35.0M | $-17.1M | ||
| Q3 24 | $-35.3M | $30.7M | ||
| Q2 24 | $-7.2M | $-25.8M | ||
| Q1 24 | $53.8M | $93.9M |
自由现金流ESPRLE
| Q4 25 | — | $-22.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-30.7M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-27.8M | ||
| Q3 24 | $-35.5M | $26.0M | ||
| Q2 24 | $-7.3M | $-32.6M | ||
| Q1 24 | $53.8M | $87.5M |
自由现金流率ESPRLE
| Q4 25 | — | -7.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -11.8% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -8.7% | ||
| Q3 24 | -68.7% | 8.2% | ||
| Q2 24 | -9.9% | -11.4% | ||
| Q1 24 | 39.0% | 17.0% |
资本支出强度ESPRLE
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 3.3% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 2.4% | ||
| Q1 24 | 0.1% | 1.2% |
现金转化率ESPRLE
| Q4 25 | — | -3.03× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LE
| U Se Commerce | $179.8M | 57% |
| Business Outfitters Revenue | $78.8M | 25% |
| Licensing And Retail | $20.2M | 6% |
| Other | $19.8M | 6% |
| Third Party | $18.9M | 6% |
